Institute of Human Genetics, Medical University Innsbruck

The Centre for Neuromuscular Diseases (NMD) Innsbruck combines the expertise of the Clinic for Neurology (adult patients), Department of Neuropaediatrics of the Clinic for Paediatrics (minors) and the Institute for Human Genetics of the Medical University of Innsbruck.

Our Centre for NMD has specific knowledge in neuropathies, myopathies, myasthenia gravis and motor neuron disease and spinal muscular atrophies (electrophysiology, multigene panel analysis, exome sequencing, clinical and genetic experience, tissue diagosis) and childhood onset neuromuscular disorders (clinical and genetic experience). Within our centre, we see about 100 newly diagnosed patients with NMD per year and offer 50-100 second opinions per year. Patients are mostly referred to us from Western Austria. Our in-house genetic laboratory processes about 300 procedures for diagnostics in the field of NMD. All genetic methods are implemented. The laboratories of the Center for NMD Innsbruck are embedded in the accredited laboratories of the ZMGI (Zentrum für Medizinische Genetik) of the Institute for Human Genetics (Head Prof. DDr. Johannes Zschocke). These laboratories analyse a wide variety of tissue types (blood, tumour tissue fresh frozen and FFPE, urine, oral mucosa, skin (fibroblast cultures), chorionic villi, amniocytes, etc.) and offer numerous molecular genetic diagnostic methods, including Sanger sequencing, Southern blot, NGS panel sequencing (Illumina: TSC, TS1ex with an extensive in-house database with regard to the TSC), exome-sequencing (in cooperation with the Institute for Human Genetics of the Helmholtz-Center Munich), transcript analysis, MLPA and many others.

The core team can rely in its dedication to patient care on all facilities comprised in the Landeskrankenhaus der Universitätskliniken Innsbruck (University Clinics Innsbruck). The available facilities include the broadest range of equipment and facilities such as radiology, laboratories, hemodynamic facilities, day hospitals, hospitalization units, nurseries, and operation theatres. The Center for NMD coordinates closely with the structures in place of the Center for Rare Diseases Innsbruck, where applicable. It also participates actively to the concept of a superordinate cross-linked biobank for rare diseases.

HCP representation

Dr Matthias Baumann MD

Matthias Baumann, MD and PhD, is head of the division of Paediatric Neurology and Lecturer in Paediatrics at the Department of Paediatrics, Medical University Innsbruck, Austria. He is a medical doctor and specialized in Paediatrics and Paediatric Neurology in Wolfsburg, Göttingen and Kassel, Germany.

Professor Sabine Rudnik-Schöneborn MD

Representative for the ERN: Sabine Rudnik-Schöneborn, MD and PhD, is Professor and Lecturer in Clinical Genetics at the Institute of Human Genetics, Medical University Innsbruck, Austria. She is a medical doctor and specialized in human genetics at the University of Bonn, Germany. She worked many years as a senior clinical geneticist at the Institute of Human Genetics, University Hospital Aachen, …

Professor Wolfgang Löscher MD

Wolfgang Löscher, MD and PhD, is Professor for Neurology at the Department of Neurology, Medical University Innsbruck, Austria. After finishing his PhD in Neuroscience at the Karolinska Institute, Stockholm, Sweden, he trained in neurology at the Departments of Neurology, Medical University Salzburg and Graz.

Location

Group membership

Institute of Human Genetics, Medical University Innsbruck participates in the following groups…

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern